1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
Zynex, Inc.

Zynex, Inc.

ZYXI
Zynex, Inc.US flagNASDAQ Global Select
0.13
USD
+0.07
- -
3.80MMarket Cap
Zynex, Inc.
ZYXI
(NASDAQ Global Select)

Recent

price

0.13

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
0.56
0.72
1.01
1.16
0.63
0.32
0.34
0.39
0.66
0.89
1.27
2.15
3.4
4.11
5.18
6.02
3.49
Revenue per Share
0.07
0.01
0.05
0.05
-0.21
-0.18
-0.08
- -
0.21
0.27
0.27
0.24
0.45
0.44
0.27
0.09
-2.38
Basic EPS, GAAP
0.08
-0.04
-0.05
-0.05
-0.03
0.02
0.01
0.04
0.23
0.23
0.17
- -
0.17
0.35
0.47
0.38
-0.68
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.06
- -
- -
0.09
- -
- -
- -
Dividend per Share
0.09
0.1
0.15
0.19
-0.02
-0.2
-0.29
-0.28
-0.07
0.14
0.4
0.63
- -
0.44
0.75
0.93
-1.4
Book Value per Share
0.23
0.24
0.3
0.34
0.14
-0.04
-0.12
-0.11
0.14
0.26
0.55
1.53
1.14
0.96
0.49
0.25
-1.33
Tangible Book Value per Share
33
34
34
34
34
34
34
34
35
36
36
37
38
38
36
32
31
Basic Weighted Avg Shares
19
24
34
40
22
11
12
13
23
32
45
80
130
158
184
192
108
Sales/Revenue/Turnover
20.42
6.48
9.08
6.9
-35.05
-51.25
-21.31
4.81
38.17
32.49
24.34
12.79
17.16
14.5
5.85
3.11
-34.35
Operating Margin (%)
1
1
1
1
1
1
- -
- -
- -
- -
1
2
2
3
4
5
5
Depreciation Expense
2
- -
2
2
-7
-6
-3
- -
7
10
9
9
17
17
10
3
-74
Net Income, GAAP
37.69
73.78
40.85
33.73
- -
- -
- -
17.86
1.72
6.5
20.51
10.63
23.21
23.2
22.63
17.45
- -
Effective Tax Rate (%)
12.75
1.45
4.58
3.92
-33.67
-55.76
-25.01
0.52
31.43
29.93
20.87
11.33
13.13
10.78
5.28
1.56
-68.35
Profit Margin (%)
6
7
8
9
4
-2
-5
-4
4
7
17
53
60
48
69
58
-42
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
3
5
27
19
72
70
8
LT Debt
7
8
10
12
5
-1
-4
-4
5
9
20
57
74
66
46
36
-41
Total Equity
29.67
4.2
14.86
11.51
- -
- -
- -
- -
384.43
102.62
46.26
20.62
19.54
17.05
7.64
4.25
- -
Return on Invested Capital (%)
77.5
9.66
26.43
17.18
- -
- -
- -
-5.78
-197.04
305
69.17
36.52
52.11
43.92
14.39
4.8
- -
Return on Capital (%)
112.72
10.59
36.7
26.68
- -
- -
- -
- -
- -
- -
98.42
47.94
145.51
199.07
44.34
10.58
-21.49
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
ST Debt
4
64
64
LT Borrowings
59
- -
- -
LT Finance Leases
10
9
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
30
30
30
Market Capitalization
70
81
45

Working Capital

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
Total Current Assets
56
46
37
Cash, Cash Equivalents & STI
24
18
13
Accounts Receivable, Net
14
10
7
Inventories
14
12
12
Total Current Liabilities
16
74
79
Payables & Accruals
12
10
15
ST Debt
4
64
64
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
34.28%
31.2%
-22.59%
Free Cash Flow
-318.41%
-778.27%
-26.63%
Net Income, GAAP
1,041.92%
-5.68%
-69.24%
Sales/Revenue/Turnover
35.49%
36.22%
4.36%
Total Cash Common Dividend
- -
- -
200%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
42
45
50
47
184
2024
47
50
50
46
192
2025
27
22
13
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.04
0.09
0.1
- -
0.27
2024
- -
0.04
0.07
-0.02
0.09
2025
-0.33
-0.66
-1.42
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
McKesson Corporation (0JZU.L)
Novolog (Pharm-Up 1966) Ltd (NVLG.TA)
Jointown Pharmaceutical Group Co., Ltd. (600998.SS)
China Meheco Group Co., Ltd. (600056.SS)
MedFirst Healthcare Services, Inc. (4175.TWO)
Oriola Oyj (ORIOLA.HE)
Business
Zynex, Inc. (Nasdaq: ZYXI) designs, manufactures, and markets non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The company offers electrotherapy products including NexWave (TENS/IFC/NMES), NeuroMove for stroke rehabilitation, InWave, E-Wave, and M-Wave; private labeled supplies such as electrodes and batteries; private labeled rehabilitation products including Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO back braces, knee and wrist bracing, and Dynacomp; and monitoring solutions such as CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter. Zynex Medical, Inc., its primary operating subsidiary, generates substantially all consolidated revenue through device sales, rentals, and related supplies and services to healthcare providers, hospitals, clinics, and patients. Founded in 1996 and headquartered at 9655 Maroon Circle, Englewood, Colorado, the company primarily serves the U.S. market with a direct sales force and supports insurance reimbursement processes. In recent developments, Zynex engages Province, LLC to evaluate strategic alternatives including capital raising, recapitalization, and restructuring amid liquidity challenges and a Tricare payment suspension; forms a Special Committee chaired by new board member Paul Aronzon to oversee these efforts; and enters a 30-day grace period on a $1.5 million interest payment for its $60 million Convertible Notes due May 2026 while negotiating with noteholders. The company reports Q3 2025 net revenue of $13.4 million, down from $50.0 million year-over-year due to payer claim denials, payment delays, Tricare adjustments, and prior workforce reductions; records a $30.7 million non-cash impairment charge on goodwill, intangibles, and assets tied to Zynex Monitoring Solutions; and appoints Steven Dyson as CEO in August 2025 to lead compliance renewal, liquidity improvement, and revenue recovery initiatives. Zynex also partners with a new entity for expanded Veterans Affairs business penetration and maintains gross margins near 60-80% through its dual sales-and-rental model.

Company News

APIChatGPT

  • prnewswire.com

    Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm

  • globenewswire.com

    Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm

  • newsfilecorp.com

    ZYXIQ CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

  • globenewswire.com

    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Zynex, Inc. Lawsuit – ZYXIQ

  • newsfilecorp.com

    Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • globenewswire.com

    Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • newsfilecorp.com

    ZYXIQ SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

  • newsfilecorp.com

    Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • globenewswire.com

    Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • globenewswire.com

    ZYXIQ Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zynex, Inc. Securities Lawsuit — The Gross Law Firm

  • prnewswire.com

    ZYXIQ UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

  • newsfilecorp.com

    Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • globenewswire.com

    ZYXIQ INVESTOR ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zynex, Inc.

  • newsfilecorp.com

    Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • newsfilecorp.com

    ZYXIQ EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

  • globenewswire.com

    Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • newsfilecorp.com

    Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • newsfilecorp.com

    ZYXIQ DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

  • prnewswire.com

    ZYXIQ Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Zynex, Inc. Securities Class Action Lawsuit -- The Gross Law Firm

  • globenewswire.com

    SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zynex, Inc. (ZYXIQ)